Holen Sie sich die Stockscreener-App
34.22
0.61%
-0.21
Handel nachbörslich:
34.22
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$34.43
Offen:
$33.91
24-Stunden-Volumen:
524.41K
Relative Volume:
1.01
Marktkapitalisierung:
$1.22B
Einnahmen:
$154.15M
Nettoeinkommen (Verlust:
$-33.58M
KGV:
-61.11
EPS:
-0.56
Netto-Cashflow:
$-20.74M
1W Leistung:
-3.61%
1M Leistung:
-19.37%
6M Leistung:
+71.70%
1J Leistung:
+241.86%
1-Tages-Spanne:
$33.75
$35.28
1-Wochen-Bereich:
$33.27
$37.34
52-Wochen-Spanne:
$9.13
$59.23
Harrow Inc Stock (HROW) Company Profile
Firmenname
Harrow Inc
Sektor
Telefon
615.733.4731
Adresse
102 WOODMONT BLVD, NASHVILLE, CA
Vergleichen Sie HROW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
34.22 | 1.22B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Bestätigt | B. Riley Securities | Buy |
| 2024-04-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-09-08 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-09-24 | Eingeleitet | Aegis Capital | Buy |
| 2021-07-02 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Harrow Inc Aktie (HROW) Neueste Nachrichten
Harrow’s Valuation Hinges On Lofty Growth Amid Persistent Financial Strains (NASDAQ:HROW) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires Shares of 32,678 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow Stock: The Triesence Relaunch (NASDAQ:HROW) - Seeking Alpha
Westside Investment Management Inc. Trims Stock Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Stifel Financial Corp Has $18.31 Million Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stock Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Verition Fund Management LLC Acquires Shares of 21,147 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
B. Riley Estimates Harrow's FY2024 Earnings (NASDAQ:HROW) - MarketBeat
BNP Paribas Financial Markets Increases Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow is Now Oversold (HROW) - Nasdaq
Harrow Inc (HROW) Stock Price Down 5.03% on Dec 3 - GuruFocus.com
Quantbot Technologies LP Purchases New Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Braidwell LP Boosts Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
HROW (Harrow) Profitability Rank : 4 (As of Sep. 2024) - GuruFocus.com
BBR Partners LLC Has $2.79 Million Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Penserra Capital Management LLC Purchases Shares of 44,180 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
US Growth Stocks With High Insider Ownership To Watch - Simply Wall St
Connor Clark & Lunn Investment Management Ltd. Takes $5.86 Million Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow subsidiary wins $34.9 million in trademark case By Investing.com - Investing.com South Africa
Harrow subsidiary wins $34.9 million in trademark case - Investing.com
Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc. - Business Wire
HROW (Harrow) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Harrow Wins $34.9M Verdict in Major Trademark Infringement Case Against OSRX - StockTitan
HROW (Harrow) Capex-to-Operating-Cash-Flow : 0.20 (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Investing : $4.2 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Change In Receivables : $-35.5 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Change In Inventory : $-1.2 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Total Inventories : $10.2 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow for Dividends : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Long-Term Debt & Capital Lease Obligation : $195.6 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Financing : $-1.5 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Operations : $4.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Operating Cash Flow per Share : $0.12 (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) PE Ratio without NRI : At Loss (As of Nov. 20, 2024) - GuruFocus.com
HROW (Harrow) Total Assets : $351.5 Mil (As of Sep. 2024) - GuruFocus.com
Former Harrow unit Melt announces results for MELT-300 to sedate for surgery - TipRanks
First Turn Management LLC Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
28,177 Shares in Harrow, Inc. (NASDAQ:HROW) Purchased by Oppenheimer & Co. Inc. - MarketBeat
Harrow stock plunges 20% on weaker-than-expected Q3 earnings - MSN
Harrow, Inc. (NASDAQ:HROW) Stock Position Lessened by Royce & Associates LP - MarketBeat
Harrow Stock: Spotlight On IHEEZO (NASDAQ:HROW) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Down 7.3%Here's Why - MarketBeat
Harrow Announces Participation in Upcoming Investor Conferences - BioSpace
Harrow Health, Inc. (NASDAQ:HROW) Q3 2024 Earnings Call Transcript - Insider Monkey
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance
Harrow Inc Com (HROW) Quarterly 10-Q Report - Quartzy
Harrow Grows Revenue 44 Percent in 2024 Third Quarter, Confirms Full-Year Guidance - Vision Monday
Harrow Inc. Reports Strong Q3 2024 Growth - TipRanks
Harrow (NASDAQ:HROW) Shares Gap DownWhat's Next? - MarketBeat
Finanzdaten der Harrow Inc-Aktie (HROW)
Umsatz
Nettogewinn
Free Cashflow
ENV
Harrow Inc-Aktie (HROW) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Apr 25 '24 |
Buy |
9.97 |
20,000 |
199,400 |
3,815,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 23 '24 |
Buy |
10.29 |
11,715 |
120,547 |
3,786,715 |
| Opaleye Management Inc. | 10% Owner |
Apr 24 '24 |
Buy |
10.15 |
8,285 |
84,093 |
3,795,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 19 '24 |
Buy |
10.56 |
29,400 |
310,390 |
3,775,000 |
| Opaleye Management Inc. | 10% Owner |
Mar 28 '24 |
Buy |
12.82 |
50,000 |
641,000 |
3,745,600 |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER |
Mar 22 '24 |
Buy |
11.59 |
9,000 |
104,310 |
2,137,525 |
| Opaleye Management Inc. | 10% Owner |
Mar 20 '24 |
Buy |
9.65 |
50,600 |
488,290 |
3,695,600 |
| SAHAREK JOHN P. | CEO of ImprimisRx |
Mar 01 '24 |
Option Exercise |
8.75 |
5,000 |
43,750 |
254,803 |
| SAHAREK JOHN P. | CEO of ImprimisRx |
Feb 20 '24 |
Option Exercise |
10.67 |
30,000 |
320,100 |
262,419 |
| BOLL ANDREW R. | CHIEF FINANCIAL OFFICER |
Feb 20 '24 |
Option Exercise |
10.67 |
45,000 |
480,150 |
586,569 |
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):